Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  Biocorp    ALCOR   FR0012788065

BIOCORP (ALCOR)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 07/20 11:20:11 am
8.9 EUR   -1.98%
04/06BIOCORP : Annual results
PU
04/06BIOCORP : 2017 Annual Results
BU
04/06BIOCORP : Slide show results
CO
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
07/16/2018 07/17/2018 07/18/2018 07/19/2018 07/20/2018 Date
9(c) 8.98(c) 8.9(c) 9.08(c) 8.9(c) Last
8 292 1 001 1 213 51 Volume
+1.81% -0.22% -0.89% +2.02% -1.98% Change
More quotes
Company
BIOCORP Production engages in the pharmaceutical and medical industry.Its products include medical and drug delivering devices which are under the names of Newject and Brandject.The company's business activities are research and development and pharmaceutical packaging.BIOCORP was founded in 2004... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on BIOCORP
04/06BIOCORP : Annual results
PU
04/06BIOCORP : 2017 Annual Results
BU
04/06BIOCORP : Slide show results
CO
04/06BIOCORP : Annual results
CO
03/14BIOCORP : Provisional calendar
CO
02/25BIZARRE REVIEW : Sci fi and time travel come together
AQ
02/16BIOCORP : and CHRONICARE Sign a Strategic Partnership to Develop an Integrated M..
BU
02/08PHARMAPACK EUROPE AWARD WINNERS 2018 : 21 years dedicated to the industry's bigg..
AQ
02/07BIOCORP : Wins Pharmapack Award For Its New Generation Auto Injector Onejet
BU
2017BIOCORP : Receives CE Mark Approval for Its Smart Cap Easylog
BU
More news
Sector news : Pharmaceuticals - NEC
07/20GLAXOSMITHKLINE : considers splitting up the group - FT
RE
07/20PFIZER : Biosimilar of Amgen's Neupogen Approved for Sale in the U.S.
DJ
07/20BAYER : to Stop Selling Essure in U.S.
DJ
07/20GLAXOSMITHKLINE : considers splitting up the group
RE
07/20GLAXOSMITHKLINE : Mulls Separation of Consumer Division -- FT
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
04/06BIOCORP: 2017 Annual Results  
02/16BIOCORP : and CHRONICARE Sign a Strategic Partnership to Develop an Integrate.. 
02/13Biocorp : Updated 2018 financial calendar  
2017BIOCORP : won CPhI Pharma Awards 2017  
2017BIOCORP: Half-Year Results as of June 30, 2017 in Line with Strategy  
More tweets
Qtime:32
Chart BIOCORP
Duration : Period :
Biocorp Technical Analysis Chart | ALCOR | FR0012788065 | 4-Traders
Technical analysis trends BIOCORP
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 17,7 €
Spread / Average Target 99%
Managers
NameTitle
Jacques Gardette Chairman & Chief Executive Officer
Eric Dessertenne Chief Operating Officer
Stéphane Chabanais Chief Financial & Administrative Officer
Alain Marcoz Director-Software Research & Development
Emilie Gardette Director
Sector and Competitors
1st jan.Capitalization (M$)
BIOCORP-20.96%42
JOHNSON & JOHNSON-9.93%337 790
PFIZER3.06%218 540
NOVARTIS-1.75%206 705
ROCHE HOLDING LTD.-5.90%200 737
MERCK AND COMPANY11.11%168 171